OPERF
VIR icon

Oregon Public Employees Retirement Fund’s Vir Biotechnology VIR Stock Holding History

Oregon Public Employees Retirement Fund’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$281K Buy
27,568
+1,800
+7% +$17.1K ﹤0.01% 1385
2026
Q1 		$231K Buy
25,768
+4,100
+19% +$32.7K ﹤0.01% 1393
2025
Q4 		$131K Buy
21,668
+400
+2% +$2.38K ﹤0.01% 1472
2025
Q3 		$121K Hold
21,268
– – ﹤0.01% 1479
2025
Q2 		$107K Buy
21,268
+100
+0.5% +$536 ﹤0.01% 1488
2025
Q1 		$137K Sell
21,168
-500
-2% -$4.45K ﹤0.01% 1455
2024
Q4 		$159K Buy
21,668
+100
+0.5% +$789 ﹤0.01% 1453
2024
Q3 		$162K Buy
21,568
+400
+2% +$3.47K ﹤0.01% 1457
2024
Q2 		$188K Sell
21,168
-1,900
-8% -$18.2K ﹤0.01% 1407
2024
Q1 		$234K Sell
23,068
-2,100
-8% -$21.4K ﹤0.01% 1378
2023
Q4 		$253K Sell
25,168
-300
-1% -$2.74K ﹤0.01% 1414
2023
Q3 		$239K Buy
25,468
+1,700
+7% +$24.2K ﹤0.01% 1524
2023
Q2 		$583K Sell
23,768
-600
-2% -$15.1K 0.01% 1252
2023
Q1 		$567K Sell
24,368
-870
-3% -$22.3K 0.01% 1244
2022
Q4 		$639K Buy
25,238
+186
+0.7% +$4.56K 0.01% 1196
2022
Q3 		$483K Buy
25,052
+852
+4% +$21.7K 0.01% 1273
2022
Q2 		$616K Buy
+24,200
New +$565K 0.01% 1025

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Oregon Public Employees Retirement Fund's VIR Position: Q2 2026 in Review

Oregon Public Employees Retirement Fund increased its Vir Biotechnology (VIR) stake by 7% in Q2 2026, buying an estimated $17.1K and bringing the position to 27,568 shares worth $281K. The position accounts for ﹤0.01% of the portfolio, ranked #1385.

Oregon Public Employees Retirement Fund first reported a position in VIR in Q2 2022 and has held it in 17 quarters since. The position peaked at $639K in Q4 2022. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Oregon Public Employees Retirement Fund held 27,568 shares of Vir Biotechnology worth $281K as of Q2 2026.
  • Oregon Public Employees Retirement Fund bought 1,800 Vir Biotechnology shares in Q2 2026, an estimated $17.1K.
  • Vir Biotechnology made up ﹤0.01% of Oregon Public Employees Retirement Fund's portfolio in Q2 2026, its #1385 holding.
  • Oregon Public Employees Retirement Fund first reported a position in Vir Biotechnology in Q2 2022 and has held it in 17 quarters since.
  • Oregon Public Employees Retirement Fund's Vir Biotechnology position peaked at $639K in Q4 2022.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Oregon Public Employees Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.